Which Stocks Could Be In Focus After Q1 Results And Corporate Updates?
STOCKS TO WATCH: POSITIVE & NEGATIVE TRIGGERS
A busy combination of Q1 FY27 results, order wins, regulatory developments, margin changes and business updates has created a sizeable list of stocks that could remain in focus.
The CNBC-TV18 graphics supplied for analysis classify stocks into two broad groups — Green for positive developments and Red for negative developments.
Among the positive names, Navin Fluorine, Neuland Laboratories, PB Fintech, Biocon, Garware Technical Fibres and SIS stand out because of strong earnings or operating metrics.
On the negative side, Cohance Lifesciences, GE Vernova T&D India, Cummins India, JK Lakshmi Cement and GNFC have important numbers or developments that warrant attention.
However, a positive fundamental trigger does not guarantee a positive stock reaction, just as a negative development does not guarantee a decline. Valuation, prior expectations and what has already been priced into the stock remain critical.
A busy combination of Q1 FY27 results, order wins, regulatory developments, margin changes and business updates has created a sizeable list of stocks that could remain in focus.
The CNBC-TV18 graphics supplied for analysis classify stocks into two broad groups — Green for positive developments and Red for negative developments.
Among the positive names, Navin Fluorine, Neuland Laboratories, PB Fintech, Biocon, Garware Technical Fibres and SIS stand out because of strong earnings or operating metrics.
On the negative side, Cohance Lifesciences, GE Vernova T&D India, Cummins India, JK Lakshmi Cement and GNFC have important numbers or developments that warrant attention.
However, a positive fundamental trigger does not guarantee a positive stock reaction, just as a negative development does not guarantee a decline. Valuation, prior expectations and what has already been priced into the stock remain critical.
Positive Stocks To Watch
| Stock | Positive Trigger |
| CONCOR | Container train operators can operate across all routes with a single licence. |
| RMC Switchgears | Orders worth ₹333.8 crore for underground cabling projects. |
| Bayer CropScience | EBITDA up 5.5%; margin at 20% versus 18.2% YoY. |
| SIS | EBITDA up 36%; revenue rises 29.7% YoY. |
| Bikaji | Revenue up 12.5%; ethnic snacks business revenue up 11.4% YoY. |
| Tenneco | EBITDA up 7.8%; revenue rises 20.2% YoY. |
| Aegis Vopak | EBITDA up 16.5%; margin at 77% versus 74.5% YoY. |
| Brigade Hotel | RevPAR up 9% YoY; EBITDA rises 9% YoY. |
| Garware Tech | EBITDA and revenue both rise 31% YoY. |
| IKS | EBITDA up 24%; margin at 33% versus 32% YoY. |
These figures provide the first layer of the watchlist. The more useful question for traders and investors, however, is which developments appear materially stronger than the others?
Navin Fluorine: One Of The Strongest Earnings Triggers
Navin Fluorine stands out prominently in the positive list.
According to the supplied CNBC-TV18 graphic:
A 73% YoY increase in EBITDA is one of the strongest earnings-growth numbers appearing anywhere across the supplied watchlist.
This makes Navin Fluorine an important stock to track from a results-reaction perspective.
The critical market question is whether such earnings strength was already reflected in expectations and valuation before the results.
According to the supplied CNBC-TV18 graphic:
Q1: STRONG
EBITDA ↑ 73% YoY
EBITDA ↑ 73% YoY
A 73% YoY increase in EBITDA is one of the strongest earnings-growth numbers appearing anywhere across the supplied watchlist.
This makes Navin Fluorine an important stock to track from a results-reaction perspective.
The critical market question is whether such earnings strength was already reflected in expectations and valuation before the results.
Neuland Laboratories: Sharp Margin Expansion
Another striking positive is Neuland Laboratories.
The supplied graphic highlights:
It also highlights a long-term CDMO partnership with Gland Pharma.
The combination of substantially higher margins and a long-term CDMO development makes Neuland one of the more noteworthy positive triggers in the supplied material.
The supplied graphic highlights:
MARGIN: 34.7%
versus
11.8% YoY
versus
11.8% YoY
It also highlights a long-term CDMO partnership with Gland Pharma.
The combination of substantially higher margins and a long-term CDMO development makes Neuland one of the more noteworthy positive triggers in the supplied material.
PB Fintech: Insurance And Lending Continue To Grow
PB Fintech, the parent of Policybazaar, is highlighted for strong underlying business growth.
Insurance Premium: ↑ 41%
Core Lending Disbursal: ↑ 33% YoY
These numbers indicate strong momentum across two important areas of the company's platform.
The significance here is that the trigger is based on underlying business activity rather than merely an accounting movement.
Insurance Premium: ↑ 41%
Core Lending Disbursal: ↑ 33% YoY
These numbers indicate strong momentum across two important areas of the company's platform.
The significance here is that the trigger is based on underlying business activity rather than merely an accounting movement.
Biocon: Biosimilars And Profit Growth Stand Out
Biocon also enters the positive watchlist after encouraging Q1 performance.
According to the supplied graphic:
Biosimilar Revenue: ↑ 16% YoY
Profit: ↑ 53.4% YoY
The profit-growth number is particularly noteworthy, while the expansion in biosimilar revenue provides an important operating indicator.
According to the supplied graphic:
Biosimilar Revenue: ↑ 16% YoY
Profit: ↑ 53.4% YoY
The profit-growth number is particularly noteworthy, while the expansion in biosimilar revenue provides an important operating indicator.
Garware Technical Fibres: Revenue And EBITDA Rise Together
Garware Tech shows a particularly clean growth combination:
The fact that both revenue and EBITDA increased by the same 31% rate is noteworthy because it indicates strong operating growth without the EBITDA growth lag highlighted in some other companies.
REVENUE ↑ 31% YoY
EBITDA ↑ 31% YoY
EBITDA ↑ 31% YoY
The fact that both revenue and EBITDA increased by the same 31% rate is noteworthy because it indicates strong operating growth without the EBITDA growth lag highlighted in some other companies.
SIS: Strong EBITDA And Revenue Growth
The numbers highlighted for SIS are also strong.
EBITDA: ↑ 36% YoY
Revenue: ↑ 29.7% YoY
EBITDA growth exceeding revenue growth makes this another result worth monitoring closely.
EBITDA: ↑ 36% YoY
Revenue: ↑ 29.7% YoY
EBITDA growth exceeding revenue growth makes this another result worth monitoring closely.
Other Important Positive Earnings Triggers
Aster DM Healthcare
EBITDA ↑ 27.5%
Revenue ↑ 22% YoY
Aegis Vopak
EBITDA ↑ 16.5%
Margin: 77% versus 74.5% YoY
Tenneco
EBITDA ↑ 7.8%
Revenue ↑ 20.2% YoY
IKS
EBITDA ↑ 24%
Margin: 33% versus 32% YoY
Brigade Hotel
RevPAR ↑ 9% YoY
EBITDA ↑ 9% YoY
Bayer CropScience
EBITDA ↑ 5.5%
Margin: 20% versus 18.2% YoY
Bikaji
Revenue ↑ 12.5%
Ethnic snacks business revenue ↑ 11.4% YoY
EBITDA ↑ 27.5%
Revenue ↑ 22% YoY
Aegis Vopak
EBITDA ↑ 16.5%
Margin: 77% versus 74.5% YoY
Tenneco
EBITDA ↑ 7.8%
Revenue ↑ 20.2% YoY
IKS
EBITDA ↑ 24%
Margin: 33% versus 32% YoY
Brigade Hotel
RevPAR ↑ 9% YoY
EBITDA ↑ 9% YoY
Bayer CropScience
EBITDA ↑ 5.5%
Margin: 20% versus 18.2% YoY
Bikaji
Revenue ↑ 12.5%
Ethnic snacks business revenue ↑ 11.4% YoY
Hindalco: Novelis Performance Beats Estimates
Hindalco is highlighted because of the Q1 performance of Novelis.
The supplied graphic states that Novelis' adjusted operational performance beat estimates and that volumes were above estimates.
Unlike some other entries in the watchlist, the graphic does not provide detailed numerical figures for this item. Therefore, the key source-supported takeaway is simply that operational performance and volumes were reported above expectations.
The supplied graphic states that Novelis' adjusted operational performance beat estimates and that volumes were above estimates.
Unlike some other entries in the watchlist, the graphic does not provide detailed numerical figures for this item. Therefore, the key source-supported takeaway is simply that operational performance and volumes were reported above expectations.
Aurobindo Pharma: European Business Grows Strongly
The supplied graphic describes Aurobindo Pharma's Q1 as largely in line with estimates.
However, one business segment stands out:
This provides an important positive operating trigger even though overall Q1 performance was described as largely in line.
However, one business segment stands out:
EUROPE BUSINESS GROWTH
27.2% YoY
27.2% YoY
This provides an important positive operating trigger even though overall Q1 performance was described as largely in line.
Corporate Developments: CONCOR, RMC Switchgears, Kolte-Patil And STL
Not every positive trigger comes from quarterly earnings.
CONCOR
The supplied graphic states that container train operators can operate across all routes with a single licence.
RMC Switchgears
The company has bagged orders worth ₹333.8 crore for underground cabling projects.
Kolte-Patil
The company has signed six society redevelopment projects in Mumbai, with GDV of ₹6,000 crore.
STL
The company has received a $210 million order from a telecom infrastructure player for CY27–29.
These are event-driven catalysts and should therefore be assessed differently from quarterly earnings surprises.
CONCOR
The supplied graphic states that container train operators can operate across all routes with a single licence.
RMC Switchgears
The company has bagged orders worth ₹333.8 crore for underground cabling projects.
Kolte-Patil
The company has signed six society redevelopment projects in Mumbai, with GDV of ₹6,000 crore.
STL
The company has received a $210 million order from a telecom infrastructure player for CY27–29.
These are event-driven catalysts and should therefore be assessed differently from quarterly earnings surprises.
Negative Stocks To Watch
| Stock | Negative Trigger |
| Power Grid | Q1 below estimates; revenue up 2.7% YoY. |
| Cummins India | Margin at lowest level in 10 quarters; MD resigns. |
| GE Vernova | Lowest margin since Q4 FY25; order inflow down 30% YoY. |
| Cohance | Revenue down 23%; EBITDA down 99% YoY. |
| IMFA | SEBI warning on insider trading by mid-management, as stated in the supplied graphic. |
| JK Lakshmi | EBITDA down 17%; margin at 13.6% versus 17.9% YoY. |
| GMM Pfaudler | EBITDA down 7%; margin at 10.1% versus 12.7% YoY. |
| eClerx | Margin down 330 bps; EBIT declines 11% QoQ. |
| GNFC | EBITDA down 18.5%; margin at 17.6% versus 21.8% YoY. |
Cohance: One Of The Weakest Earnings Triggers
The numbers highlighted for Cohance are among the weakest in the supplied watchlist.
The 99% YoY EBITDA decline is particularly significant and creates an obvious negative earnings trigger.
However, the actual market reaction will still depend on expectations, management commentary and how much weakness had already been discounted by the share price.
REVENUE ↓ 23% YoY
EBITDA ↓ 99% YoY
EBITDA ↓ 99% YoY
The 99% YoY EBITDA decline is particularly significant and creates an obvious negative earnings trigger.
However, the actual market reaction will still depend on expectations, management commentary and how much weakness had already been discounted by the share price.
GE Vernova: Margin And Order Inflow Both Raise Concerns
GE Vernova faces two negative indicators according to the supplied graphic.
• Margin at the lowest level since Q4 FY25
• Order inflow ↓ 30% YoY
Order inflow is particularly relevant for businesses where future revenue visibility depends heavily on the order book.
The simultaneous presence of weaker margins and lower order inflow therefore makes this an important stock to monitor.
• Margin at the lowest level since Q4 FY25
• Order inflow ↓ 30% YoY
Order inflow is particularly relevant for businesses where future revenue visibility depends heavily on the order book.
The simultaneous presence of weaker margins and lower order inflow therefore makes this an important stock to monitor.
Cummins India: Margin Weakness Plus Management Change
The supplied graphic flags Cummins India for two reasons:
Margin at its lowest level in 10 quarters
and
MD resignation.
This combines an operating issue with a management development, which could make the stock particularly sensitive to investor interpretation of future profitability and leadership continuity.
Margin at its lowest level in 10 quarters
and
MD resignation.
This combines an operating issue with a management development, which could make the stock particularly sensitive to investor interpretation of future profitability and leadership continuity.
JK Lakshmi, GNFC And GMM Pfaudler Show Margin Pressure
JK Lakshmi
EBITDA ↓ 17%
Margin: 13.6% versus 17.9% YoY
GNFC
EBITDA ↓ 18.5%
Margin: 17.6% versus 21.8% YoY
GMM Pfaudler
EBITDA ↓ 7%
Margin: 10.1% versus 12.7% YoY
The common thread among all three is margin deterioration.
Markets frequently pay close attention to margins because they help indicate how effectively revenue is being converted into operating profitability.
EBITDA ↓ 17%
Margin: 13.6% versus 17.9% YoY
GNFC
EBITDA ↓ 18.5%
Margin: 17.6% versus 21.8% YoY
GMM Pfaudler
EBITDA ↓ 7%
Margin: 10.1% versus 12.7% YoY
The common thread among all three is margin deterioration.
Markets frequently pay close attention to margins because they help indicate how effectively revenue is being converted into operating profitability.
eClerx: Sequential Profitability Pressure
The supplied graphic highlights two concerns for eClerx:
Margin ↓ 330 basis points
EBIT ↓ 11% QoQ
Unlike several other comparisons in the watchlist, the EBIT decline here is explicitly quarter-on-quarter, rather than year-on-year.
That distinction should be preserved when interpreting the result.
Margin ↓ 330 basis points
EBIT ↓ 11% QoQ
Unlike several other comparisons in the watchlist, the EBIT decline here is explicitly quarter-on-quarter, rather than year-on-year.
That distinction should be preserved when interpreting the result.
Power Grid: Q1 Below Estimates
Power Grid is classified in the negative group because its Q1 performance was below estimates.
Revenue nevertheless increased 2.7% YoY.
This is an important reminder that a company does not necessarily need to report an absolute revenue decline to disappoint the market.
Share prices frequently react to the difference between actual performance and market expectations.
Revenue nevertheless increased 2.7% YoY.
This is an important reminder that a company does not necessarily need to report an absolute revenue decline to disappoint the market.
Share prices frequently react to the difference between actual performance and market expectations.
Positive Catalyst Priority Watchlist
Based purely on the strength of the developments and numbers highlighted in the supplied graphics — rather than predicting the share-price reaction — the positive watchlist can be prioritised as follows:
🟢 HIGH-ATTENTION POSITIVE TRIGGERS
1. NAVIN FLUORINE
EBITDA ↑ 73% YoY
2. NEULAND LABORATORIES
Margin 34.7% vs 11.8% YoY
+ Long-term CDMO partnership
3. PB FINTECH
Insurance Premium ↑ 41%
Core Lending Disbursal ↑ 33% YoY
4. GARWARE TECH
Revenue & EBITDA ↑ 31% YoY each
5. SIS
EBITDA ↑ 36%
Revenue ↑ 29.7% YoY
6. BIOCON
Biosimilar Revenue ↑ 16%
Profit ↑ 53.4% YoY
1. NAVIN FLUORINE
EBITDA ↑ 73% YoY
2. NEULAND LABORATORIES
Margin 34.7% vs 11.8% YoY
+ Long-term CDMO partnership
3. PB FINTECH
Insurance Premium ↑ 41%
Core Lending Disbursal ↑ 33% YoY
4. GARWARE TECH
Revenue & EBITDA ↑ 31% YoY each
5. SIS
EBITDA ↑ 36%
Revenue ↑ 29.7% YoY
6. BIOCON
Biosimilar Revenue ↑ 16%
Profit ↑ 53.4% YoY
Negative Catalyst Priority Watchlist
Based on the negative developments specifically highlighted in the supplied material:
🔴 HIGH-ATTENTION NEGATIVE TRIGGERS
1. COHANCE
Revenue ↓ 23%
EBITDA ↓ 99% YoY
2. GE VERNOVA
Lowest margin since Q4 FY25
Order inflow ↓ 30% YoY
3. CUMMINS INDIA
Lowest margin in 10 quarters
+ MD resignation
4. JK LAKSHMI
EBITDA ↓ 17%
Sharp margin contraction
5. GNFC
EBITDA ↓ 18.5%
Margin contraction
6. GMM PFAUDLER
EBITDA ↓ 7%
Margin falls to 10.1%
1. COHANCE
Revenue ↓ 23%
EBITDA ↓ 99% YoY
2. GE VERNOVA
Lowest margin since Q4 FY25
Order inflow ↓ 30% YoY
3. CUMMINS INDIA
Lowest margin in 10 quarters
+ MD resignation
4. JK LAKSHMI
EBITDA ↓ 17%
Sharp margin contraction
5. GNFC
EBITDA ↓ 18.5%
Margin contraction
6. GMM PFAUDLER
EBITDA ↓ 7%
Margin falls to 10.1%
Green Does Not Automatically Mean Buy
This is the most important point for traders.
A company can report excellent earnings and still see its share price decline.
Why?
• The result may already be priced in.
• Market expectations may have been even higher.
• Management guidance may disappoint.
• Valuation may already be expensive.
• Traders may use the event to book profits.
The reverse applies to weak results. A stock can sometimes rise despite disappointing numbers if expectations were extremely poor or if management provides a significantly better forward outlook.
Therefore:
A company can report excellent earnings and still see its share price decline.
Why?
• The result may already be priced in.
• Market expectations may have been even higher.
• Management guidance may disappoint.
• Valuation may already be expensive.
• Traders may use the event to book profits.
The reverse applies to weak results. A stock can sometimes rise despite disappointing numbers if expectations were extremely poor or if management provides a significantly better forward outlook.
Therefore:
POSITIVE NEWS ≠ AUTOMATIC BUY
NEGATIVE NEWS ≠ AUTOMATIC SELL
NEGATIVE NEWS ≠ AUTOMATIC SELL
What Should Intraday Traders Watch?
For result- and news-driven stocks, the opening reaction alone can be misleading.
A more disciplined approach is to observe:
• Opening gap
• First 5–15 minute price behaviour
• Trading volume
• Whether the opening high or low is sustained
• VWAP behaviour
• Sector strength or weakness
• Whether initial gains attract profit-booking
• Whether initial weakness attracts buying
Stocks with unusually strong fundamental catalysts can generate substantial volatility, making confirmation particularly important.
A more disciplined approach is to observe:
• Opening gap
• First 5–15 minute price behaviour
• Trading volume
• Whether the opening high or low is sustained
• VWAP behaviour
• Sector strength or weakness
• Whether initial gains attract profit-booking
• Whether initial weakness attracts buying
Stocks with unusually strong fundamental catalysts can generate substantial volatility, making confirmation particularly important.
Final Stocks To Watch Scorecard
| Category | Stocks To Watch |
| 🟢 Strong Earnings Growth | Navin Fluorine, Neuland Labs, SIS, Garware Tech |
| 🟢 Business Momentum | PB Fintech, Biocon, Aurobindo Pharma |
| 🟢 Order / Project Trigger | RMC Switchgears, Kolte-Patil, STL |
| 🟢 Regulatory / Policy Trigger | CONCOR |
| 🔴 Weak Earnings | Cohance, JK Lakshmi, GNFC, GMM Pfaudler |
| 🔴 Margin / Order Concerns | GE Vernova, Cummins India, eClerx |
| 🔴 Below Expectations | Power Grid |
| 🔴 Regulatory Development | IMFA |
Investor Takeaway
Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Regd Investment Adviser, observes that the supplied watchlist contains an unusually broad combination of earnings surprises, margin movements, order wins and corporate developments, making individual stock selection more important than simply following the headline indices.Among the positive results, Navin Fluorine's 73% YoY EBITDA growth is particularly striking. Neuland Laboratories' margin expansion, PB Fintech's operating growth, SIS's revenue and EBITDA performance and Garware Tech's 31% growth in both revenue and EBITDA also deserve attention.
Among the negative developments, Cohance's 99% YoY EBITDA decline is the most dramatic number in the supplied material. GE Vernova's combination of margin weakness and 30% lower order inflow also deserves close scrutiny, while Cummins India combines a ten-quarter-low margin with a management change.
The crucial distinction for investors and traders is between a strong fundamental trigger and an attractive entry price. They are not necessarily the same thing.
The better strategy is to identify the strongest catalysts first and then allow price action, valuation and market expectations to determine whether an actual opportunity exists.
Read Free content at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Source: CNBC-TV18 Stocks To Watch graphics supplied for analysis.
Source Note: Company names, financial figures, order values and developments in this article have been extracted from the supplied CNBC-TV18 graphics. Descriptions such as positive, negative, stronger and weaker refer to the developments shown in those graphics and subsequent analytical interpretation; they do not constitute predictions of share-price performance.
Written by Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Disclaimer: This article is for educational and informational purposes only. It is not a recommendation to buy, sell or hold any security. Quarterly financial results, corporate announcements and news can cause substantial volatility, and a positive or negative fundamental development does not guarantee a corresponding share-price movement. Investors and traders should independently verify current company disclosures, financial results, market prices and other relevant information before taking any investment or trading decision.
Source Note: Company names, financial figures, order values and developments in this article have been extracted from the supplied CNBC-TV18 graphics. Descriptions such as positive, negative, stronger and weaker refer to the developments shown in those graphics and subsequent analytical interpretation; they do not constitute predictions of share-price performance.
Written by Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Disclaimer: This article is for educational and informational purposes only. It is not a recommendation to buy, sell or hold any security. Quarterly financial results, corporate announcements and news can cause substantial volatility, and a positive or negative fundamental development does not guarantee a corresponding share-price movement. Investors and traders should independently verify current company disclosures, financial results, market prices and other relevant information before taking any investment or trading decision.
